| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |